| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762459397P | 2017-02-15 | 2017-02-15 | |
| PCT/US2018/018389WO2018152340A1 (en) | 2017-02-15 | 2018-02-15 | Compositions and methods for activating nk cells |
| Publication Number | Publication Date |
|---|---|
| SG11201908472VAtrue SG11201908472VA (en) | 2019-10-30 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201908472VSG11201908472VA (en) | 2017-02-15 | 2018-02-15 | Compositions and methods for activating nk cells |
| Country | Link |
|---|---|
| US (3) | US20200306300A1 (en) |
| EP (1) | EP3582856A4 (en) |
| JP (2) | JP7374769B2 (en) |
| KR (1) | KR20190129046A (en) |
| CN (1) | CN110799201A (en) |
| AU (1) | AU2018221745A1 (en) |
| CA (1) | CA3059058A1 (en) |
| SG (1) | SG11201908472VA (en) |
| WO (1) | WO2018152340A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020102360A1 (en)* | 2018-11-13 | 2020-05-22 | Cn.Usa Biotech Holdings, Inc. | Compositions containing an expanded and enriched population of superactivated cytokine killer t cells and methods for making same |
| EP3982983A4 (en)* | 2019-06-14 | 2023-11-15 | G Tech Bio LLC | Activated lymphocytic cells and methods of using the same to treat cancer and infectious conditions |
| WO2021022124A1 (en)* | 2019-08-01 | 2021-02-04 | The Regents Of The University Of California | Systems and methods for evaluating nk cells |
| CA3144018A1 (en)* | 2019-08-05 | 2021-02-11 | The Board Of Trustees Of The Leland Stanford Junior University | Manipulation and use of antigen-specific regulatory t cells |
| CN111235106B (en)* | 2019-08-30 | 2022-08-05 | 武汉大学 | A kind of Aptamer-CD3+ T cell targeting tumor cells and its construction method and application |
| CN112266413A (en)* | 2020-10-22 | 2021-01-26 | 中国人民解放军海军军医大学 | Factors, feeder cell lines and methods for expanding NK cells and enhancing killing activity thereof |
| KR102698871B1 (en)* | 2021-09-10 | 2024-08-28 | 이종균 | Biological composition for preventing or treating cancer comprising dendritic cells, natural killer cells and cytotoxic T cells |
| WO2023114445A1 (en)* | 2021-12-16 | 2023-06-22 | The Regents Of The University Of California | Prevention of bone loss |
| KR102472076B1 (en)* | 2021-12-16 | 2022-11-30 | 주식회사 아리아코스메틱 | Manufacturing method for cosmetic with microbiome lactic acid bacteria using NK cell culture medium composition |
| CN115537397B (en)* | 2022-12-02 | 2023-03-24 | 广东先康达细胞库有限公司 | NK cell induction culture medium and culture method thereof |
| CN119410580A (en)* | 2024-12-04 | 2025-02-11 | 潍坊吉涛医学科技有限公司 | A method for in vitro expansion and cultivation of NK cells |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5587384A (en) | 1994-02-04 | 1996-12-24 | The Johns Hopkins University | Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity |
| US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| BR112012003103A2 (en) | 2009-08-10 | 2016-04-19 | Univ Texas | treatment of tumor astrocyte cells with endothelin receptor inhibitor |
| US9763982B2 (en) | 2010-06-29 | 2017-09-19 | The Regents Of The University Of California | Depletion of cancer stem cells |
| EP3012271A1 (en) | 2014-10-24 | 2016-04-27 | Effimune | Method and compositions for inducing differentiation of myeloid derived suppressor cell to treat cancer and infectious diseases |
| KR101697473B1 (en)* | 2014-11-26 | 2017-01-18 | 주식회사 녹십자랩셀 | Method for Preparation of Natural Killer Cells Using T Cells |
| US20180171298A1 (en)* | 2015-06-30 | 2018-06-21 | Cellectis | Methods for improving functionality in nk cell by gene inactivation using specific endonuclease |
| Publication number | Publication date |
|---|---|
| EP3582856A4 (en) | 2021-03-10 |
| US20200306300A1 (en) | 2020-10-01 |
| KR20190129046A (en) | 2019-11-19 |
| WO2018152340A1 (en) | 2018-08-23 |
| US20240165152A1 (en) | 2024-05-23 |
| CN110799201A (en) | 2020-02-14 |
| AU2018221745A1 (en) | 2019-10-03 |
| CA3059058A1 (en) | 2018-08-23 |
| JP7374769B2 (en) | 2023-11-07 |
| US20250049859A1 (en) | 2025-02-13 |
| JP2020507343A (en) | 2020-03-12 |
| JP2024010093A (en) | 2024-01-23 |
| EP3582856A1 (en) | 2019-12-25 |
| Publication | Publication Date | Title |
|---|---|---|
| SG11201908472VA (en) | Compositions and methods for activating nk cells | |
| SG11201809857TA (en) | Anti-CTLA-4 Antibodies | |
| SG11201907857RA (en) | Edible and biodegradable utensils | |
| SG11201907650RA (en) | Personal therapy and exercise monitoring and oversight devices, systems, and related methods | |
| SG11201901628XA (en) | Methods and compositions for spinal cord cells | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201910019PA (en) | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | |
| SG11201811184UA (en) | Lag -3 binding members | |
| SG11201806485RA (en) | Pyrrolobenzodiazepine conjugates | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201906660TA (en) | Anti-tgf-beta antibodies and their use | |
| SG11201809374VA (en) | Cd40l-fc fusion polypeptides and methods of use thereof | |
| SG11201909963YA (en) | Methods for treating dravet syndrome | |
| SG11201810887UA (en) | Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof | |
| SG11201805950UA (en) | Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them | |
| SG11201809534UA (en) | Methods of treating autoimmune disease using allogeneic t cells | |
| SG11201909303TA (en) | Point of delivery cold slurry generation | |
| SG11201903427UA (en) | Deodorizing agent comprising zinc neodecanoate | |
| SG11201906807VA (en) | Compositions and methods for promoting hair growth with mpc1 inhibitors | |
| SG11201910195WA (en) | Methods for trapping and barcoding discrete biological units in hydrogel | |
| SG11201909003YA (en) | Integrated vascular access device and anchor pad | |
| SG11201909501TA (en) | Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro | |
| SG11201901172QA (en) | A method for manufacturing a fuel component | |
| SG11201906383WA (en) | A layered medical data computer architecture |